Rigel Pharmaceuticals RIGL Goodwill and intangible assets, net
Goodwill and intangible assets, net at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's goodwill and intangible assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's goodwill and intangible assets, net?
- Rigel Pharmaceuticals (RIGL) reported goodwill and intangible assets, net of $24.16M in Q1 2026.
- How has Rigel Pharmaceuticals's goodwill and intangible assets, net changed year-over-year?
- Rigel Pharmaceuticals's goodwill and intangible assets, net decreased by 8.9% year-over-year, from $26.51M to $24.16M.
- What is the long-term trend for Rigel Pharmaceuticals's goodwill and intangible assets, net?
- Over 3 years (2022 to 2025), Rigel Pharmaceuticals's goodwill and intangible assets, net has grown at a 18.3% compound annual growth rate (CAGR), from $14.95M to $24.75M.